Showing results (151-160 of 299) with videos related to
Sort By:
Pageof 30
Cancer Chemotherapy and Pharmacology|July 22, 2018
A safety, tolerability, and pharmacokinetic analysis of two phase I studies of multitargeted small molecule tyrosine kinase inhibitor XL647 with an intermittent and continuous dosing schedule in patients with advanced solid malignanciesMillie Das, Sukhmani K Padda, Adam Frymoyer, et al.Cancer|October 25, 2023
Risk model-based management for second primary lung cancer among lung cancer survivors through a validated risk prediction modelEunji Choi, Sophia J Luo, Victoria Y Ding, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 21, 2015
Incidence trends of lung cancer by immigration status among Chinese AmericansScarlett Lin Gomez, Juan Yang, Shih-Wen Lin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Phase II study of gefitinib, fluorouracil, leucovorin, and oxaliplatin therapy in previously treated patients with metastatic colorectal cancerTimothy Kuo, Cheryl D Cho, Joanne Halsey, et al.Lung Cancer (Amsterdam, Netherlands)|March 3, 2018
Randomized phase 2 study of tivantinib plus erlotinib versus single-agent chemotherapy in previously treated KRAS mutant advanced non-small cell lung cancerDavid E Gerber, Mark A Socinski, Joel W Neal, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2018
EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical OutcomesNicolas Marcoux, Scott N Gettinger, Grainne O'Kane, et al.JAMA Oncology|October 26, 2023
Risk Model-Based Lung Cancer Screening and Racial and Ethnic Disparities in the USEunji Choi, Victoria Y Ding, Sophia J Luo, et al.Clinical Lung Cancer|September 27, 2024
Smoking and the Risk of Second Primary Lung Cancer Among Breast Cancer Survivors from the Population-Based UK Biobank StudyAnna Graber-Naidich, Eunji Choi, Julie T Wu, et al.Lung Cancer (Amsterdam, Netherlands)|July 24, 2018
Synchronous primary lung adenocarcinomas harboring distinct MET Exon 14 splice site mutationsSamantha X Y Wang, Li Lei, Haiwei H Guo, et al.Annals of Translational Medicine|January 20, 2023
Diagnosis and treatment of pericardial mesothelioma by mediastinal mass resection: a case reportLubiao Liang, Xiao Zhang, Xixian Ke, et al.Pageof 30